Treatment and prophylaxis of amyloidosis

Details for Australian Patent Application No. 2008345022 (hide)

Owner Elan Pharmaceuticals, Inc.

Inventors Schenk, Dale B.; Wall, Jonathan; Saldanha, Jose; Seubert, Peter A.

Agent Shelston IP

Pub. Number AU-A-2008345022

PCT Pub. Number WO2009/086539

Priority 61/007,544 28.12.07 US; 61/095,932 10.09.08 US

Filing date 29 December 2008

Wipo publication date 9 July 2009

International Classifications

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/086539 Priority application(s): WO2009/086539

16 September 2010 Alteration of Name

  The name of the applicant has been altered to Elan Pharmaceuticals, Inc.; University of Tennessee Research Foundation 2009 Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008345028-Photoluminescent backing sheet for photovoltaic modules

2008345016-Ultra-resilient fabric